Isolere Bio
Durham
About Isolere Bio
Isolere Bio is a Healthcare Company.Monoclonal antibodies make up an effective and rapidly growing class of drugs. They are also critical research tools and essential for the development of many new diagnostics. Isolere Bio was co-founded with the vision of simplifying and streamlining the purification of biotherapeutics to improve global access to these important drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Funding stage: M&A
- Last round: Grant (Sep 2022)
- Website: isolerebio.com
- Phone: 719-322-4394
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/isolere-bio-22072 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.